Singapore, Sept. 2 -- MGI Tech, a company dedicated to developing core tools and technologies that drive innovation in life sciences, and JCBio Co., a leading South Korean biotechnology company, have signed a Memorandum of Understanding (MoU) to launch the DCS Lab Project, a landmark collaboration.

The initiative aims to accelerate multi-omics research, novel sequencing applications, precision medicine, clinical translation, and AI-driven data insights in South Korea. By combining MGI's advanced omics technologies with JCBio's local expertise, the partnership empowers researchers and clinicians while strengthening South Korea's role as a regional leader in genomics and biotechnology.

In an era where multi-omics research is reshaping hea...